2-methylpentane has been researched along with Pulmonary Disease, Chronic Obstructive in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gross, NJ | 1 |
| Beeh, KM; Beier, J; Bock, D; Kirsten, A; Magnussen, H; Meyer, M; Meyer-Sabellek, W; Pedersen, F; Schierhorn, K; Vollhardt, K; Watz, H; Woischwill, C | 1 |
| Romano, SJ | 1 |
1 review(s) available for 2-methylpentane and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Selectin antagonists : therapeutic potential in asthma and COPD.
Topics: Animals; Asthma; Hexanes; Humans; Inflammation; Lewis X Antigen; Mannose; Oligosaccharides; P-Selectin; Pulmonary Disease, Chronic Obstructive; Selectins; Sialyl Lewis X Antigen | 2005 |
1 trial(s) available for 2-methylpentane and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Inhaled pan-selectin antagonist Bimosiamose attenuates airway inflammation in COPD.
Topics: Administration, Inhalation; Aged; Asthma; Cross-Over Studies; Double-Blind Method; Female; Hexanes; Humans; Interleukin-8; Male; Mannose; Matrix Metalloproteinase 9; Middle Aged; Pulmonary Disease, Chronic Obstructive; Selectins | 2013 |
1 other study(ies) available for 2-methylpentane and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
The COPD pipeline XXII.
Topics: Anti-Inflammatory Agents; Bronchoscopy; Drug Discovery; Hexanes; Humans; Influenza Vaccines; Lung; Mannose; Organ Size; Pulmonary Disease, Chronic Obstructive; RNA, Antisense; Tobacco Use Cessation Devices; Tumor Necrosis Factor-alpha | 2013 |